Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Withdrawn
Dey, L.P.
Phase 4
2008-03-01
The purpose of this study is to compare the effects of nebulized formoterol fumarate
(Perforomist) to dry-powder inhaler formoterol fumarate (Foradil). Perforomist is a solution
that is made into very fine spray (using a nebulizer) that is then breathed in over 10-15
minutes. Foradil is taken in a single quick, deep inhalation.
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Withdrawn
University of California, Los Angeles
Phase 4
2008-03-01
The purpose of this study is to compare the effects of nebulized formoterol fumarate
(Perforomist) to dry-powder inhaler formoterol fumarate (Foradil). Perforomist is a solution
that is made into very fine spray (using a nebulizer) that is then breathed in over 10-15
minutes. Foradil is taken in a single quick, deep inhalation.
Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)
Completed
Dey
Phase 4
2012-03-01
This study is a multi-center, randomized, placebo-controlled study to evaluate the long-term
safety of Perforomist® inhalation therapy in subjects with Chronic Obstructive Pulmonary
Disease (COPD). Individual participation is approximately 54 weeks, including 52 weeks of
double-blind treatment.
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
Completed
Mylan Specialty L.P.
N/A
2015-02-01
The purpose of this study is to compare drug delivery and lung function after treatment with
formoterol from a nebulizer versus a dry powder inhaler (DPI) in patients recovering from
severe exacerbations of COPD. This is to determine if one device is superior in providing
better lung function and drug deposition in this clinical setting.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
